Skip to main content

Table 3 Odds ratio of abnormal left ventricular geometric patterns according to continuous or tertiles of nontraditional lipid profiles

From: The impact of nontraditional lipid profiles on left ventricular geometric abnormalities in general Chinese population

Variables

Concentric LV remodeling

Eccentric LVH

Concentric LVH

 

Model 1

Model 2

Model 1

Model 2

Model 1

Model 2

TC/HDL-C ratio (Per 1 SD increase)

0.998 (0.922–1.079)

0.973 (0.894–1.059)

1.261 (1.196–1.329)a

1.051 (0.990–1.116)

1.382 (1.276–1.496)a

1.150 (1.050–1.260)b

Tertile of TC/HDL-C ratio

 T1 (≤3.35)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

 T2 (3.35–4.29)

1.044 (0.863–1.264)

1.010 (0.832–1.226)

1.433 (1.242–1.653)a

1.183 (1.017–1.375)c

1.673 (1.300–2.152)a

1.463 (1.126–1.900)b

 T3 (> 4.29)

1.084 (0.896–1.312)

1.032 (0.844–1.261)

1.829 (1.592–2.101)a

1.168 (1.003–1.361)c

2.593 (2.046–3.287)a

1.639 (1.268–2.120)a

 P for trend

0.405

0.759

< 0.001

0.059

< 0.001

< 0.001

TG/HDL-C ratio (Per 1 SD increase)

1.055 (0.976–1.140)

1.047 (0.963–1.138)

1.278 (1.211–1.349)a

1.063 (0.999–1.131)

1.399 (1.285–1.522)a

1.134 (1.030–1.249)c

Tertile of TG/HDL-C ratio

 T1 (≤0.68)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

 T2 (0.68–1.28)

1.116 (0.920–1.352)

1.082 (0.890–1.315)

1.446 (1.252–1.670)a

1.171 (1.006–1.363)c

1.611 (1.259–2.062)a

1.295 (1.001–1.675)c

 T3 (> 1.28)

1.194 (0.986–1.445)

1.162 (0.950–1.420)

1.966 (1.710–2.259)a

1.260 (1.082–1.467)b

2.381 (1.885–3.008)a

1.413 (1.097–1.821)b

 P for trend

0.070

0.144

< 0.001

0.003

< 0.001

0.009

LDL-C/HDL-C ratio (Per 1 SD increase)

0.984 (0.909–1.064)

0.960 (0.882–1.045)

1.237 (1.174–1.304)a

1.014 (0.955–1.077)

1.404 (1.298–1.518)a

1.158 (1.059–1.266)b

Tertile of LDL-C/HDL-C ratio

 T1 (≤1.79)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

 T2 (1.79–2.44)

0.963 (0.794–1.166)

0.934 (0.768–1.135)

1.465 (1.272–1.688)a

1.131 (0.974–1.314)

1.686 (1.311–2.168)a

1.346 (1.035–1.750)c

 T3 (> 2.44)

1.072 (0.888–1.295)

1.029 (0.844–1.255)

1.677 (1.459–1.927)a

1.001 (0.858–1.168)

2.534 (1.999–3.212)a

1.523 (1.176–1.971)b

 P for trend

0.465

0.775

< 0.001

0.878

< 0.001

0.002

Non-HDL-C (Per 1 SD increase)

1.106 (1.026–1.192)c

1.045 (0.964–1.133)

1.260 (1.196–1.327)a

1.021 (0.963–1.084)

1.435 (1.329–1.549)a

1.174 (1.075–1.281)a

Tertile of Non-HDL-C

 Tertile 1 (≤3.33)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

1.000 (reference)

 Tertile 2 (3.33–4.17)

1.111 (0.915–1.349)

1.024 (0.841–1.247)

1.447 (1.255–1.669)a

1.101 (0.947–1.280)

1.846 (1.431–2.381)a

1384 (1.063–1.802)c

 Tertile 3 (> 4.17)

1.225 (1.009–1.486)

1.055 (0.861–1.292)

1.748 (1.518–2.012)a

1.020 (0.875–1.190)

2.623 (2.054–3.351)a

1.454 (1.121–1.888)b

 P for trend

0.040

0.606

< 0.001

0.911

< 0.001

0.008

  1. Abbreviations: OR odd ratio, 95% CI 95% confidence interval, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, Non-HDL-C non-high-density lipoprotein cholesterol, LVH left ventricular hypertrophy. Model 1: unadjusted; Model 2: adjusted for age, sex, race, education level, family income, diet score, smoking and drinking status, physical activity, obesity, hypertension, diabetes, history of cardiovascular disease, antihypertensive medication use, and antidiabetic medication use
  2. aP < 0.001, bP < 0.01, cP < 0.05